Related Experiment Videos
[Interleukin-1 beta in patients with primary immunocomplex glomerulonephritis]
Vojnosanitetski Pregled
|June 23, 2001
Summary
Elevated urinary Interleukin-1 beta (IL-1 beta) levels are common in primary immunocomplex glomerulonephritis, indicating its role in disease pathogenesis. Urinary IL-1 beta may serve as a non-invasive marker for diagnosing and monitoring glomerulonephritis activity.
Area of Science:
- Immunology
- Nephrology
- Cytokine research
Context:
- Interleukin-1 (IL-1) is a key pro-inflammatory cytokine implicated in various inflammatory conditions.
- Previous studies suggest IL-1's involvement in the pathogenesis of glomerulonephritis.
- Primary immunocomplex glomerulonephritis is a significant cause of kidney disease.
Purpose:
- To investigate the urinary levels of Interleukin-1 beta (IL-1 beta) in patients with primary immunocomplex glomerulonephritis.
- To assess the diagnostic significance of urinary IL-1 beta in this patient population.
- To explore the correlation between urinary IL-1 beta levels and histological types of glomerulonephritis.
Summary:
- This prospective study analyzed 96 patients with primary immunocomplex glomerulonephritis.
- Elevated urinary IL-1 beta was detected in 49.4% of patients, with significantly higher mean concentrations compared to controls (p < 0.05).
- Urinary IL-1 beta levels did not correlate with histological subtypes but may reflect disease activity.
Impact:
- Urinary IL-1 beta emerges as a potential non-invasive biomarker for diagnosing primary immunocomplex glomerulonephritis.
- Measurement of urinary IL-1 beta may aid in monitoring glomerulonephritis progression and disease activity.
- This finding offers a new avenue for non-invasive assessment in nephrology practice.